Zordani Richard A. Jr.
Director
1 company
Insider Signal Score
52
AverageTrades Analyzed
7
12M Win Rate
57.1%
Avg 3M Return
+6.4%
Avg 12M Return
+18.9%
Zordani Richard A. Jr. is a Director at GALT. Recent filings cover 8 purchases and 0 sales. Those positions are worth an estimated $145K at current prices.
Our model assigns Zordani Richard A. Jr. a middling insider score of 52/100, based on 7 past trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of +18.9%.
Zordani Richard A. Jr.'s largest disclosed position is in GALT as Director, worth about $145K. Net of sales, the recent Form 4 record there shows accumulation of 29,500 shares.
Holdings by Company
GALTDec 24, 2024
Current Shares42.1K
Value$145.2K
Net Activity+29.5K
Bought: 29.5KSold: 0
Transaction History
Showing 6 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 10,000 | $0.82 | $8,164.00 | +31.2% | +96.3% | +379.4% | |
| Aug 23, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 3,500 | $2.30 | $8,050.00 | +5.7% | +17.7% | +77.5% | |
| Apr 30, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 1,000 | $3.52 | $3,520.00 | New | -26.8% | -61.0% | |
| Jul 28, 2022 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $2.50 | $12,500.00 | +20.3% | -42.3% | -39.9% | |
| Apr 4, 2022 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $1.61 | $8,025.00 | +25.5% | -8.1% | +21.7% | |
| Jan 14, 2022 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $2.02 | $10,100.00 | +34.3% | -13.9% | -43.6% |